The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - Genentech
Stock and Other Ownership Interests - Genentech
An open-label, single-arm, phase II study of pertuzumab with high-dose trastuzumab for treatment of central nervous system (CNS) progression post-radiotherapy in patients (pts) with HER2-positive metastatic breast cancer (MBC): PATRICIA.
 
Nancy U. Lin
Consulting or Advisory Role - Novartis
Research Funding - Array BioPharma; Genentech; Geron; GlaxoSmithKline; Kadmon; Novartis
 
Catherine Lai
Employment - Genentech/Roche
Stock and Other Ownership Interests - Biomarin (I); Gilead Sciences; Pfizer; Roche/Genentech; Teva
 
Andrea Lacasia
Employment - Genentech
Stock and Other Ownership Interests - Genentech
 
Alisha Stein
Employment - Genentech
Stock and Other Ownership Interests - Roche/Genentech
 
Bongin Yoo
Employment - Genentech
Stock and Other Ownership Interests - Roche/Genentech
 
Anita Fung
No Relationships to Disclose
 
Mark D. Pegram
Employment - Dava Oncology (I)
Consulting or Advisory Role - Genenetech, Pfizer, Novartis, AstraZeneca
Expert Testimony - Novartis
Travel, Accommodations, Expenses - Genentech, Pfizer, Novartis
Other Relationship - Genentech, Pfizer, Novartis, AstraZeneca